Elevated levels of β-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1)

Clinical and Experimental Immunology

Volumn 118, Issue 3, 1999, Pages 417-422

  Seki, M ^a   Kadota, J I ^a   Higashiyama, Y ^a   Iida, K ^a   Iwashita, T ^a   Sasaki, E ^a   Maesaki, S ^a   Tomono, K ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokines; Bronchoalveolar lavage; HTLV 1; IL 2R (CD25)

Indexed keywords

BETA CHEMOKINE; CD3 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; RANTES;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LUNG DISEASE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; T LYMPHOCYTE; VIRUS PATHOGENESIS;

ADULT; AGED; ANTIGENS, CD3; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHEMOKINE CCL2; CHEMOKINES, CC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HTLV-I INFECTIONS; HUMANS; LUNG DISEASES; LYMPHOCYTOSIS; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; RANTES; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS;

EID: 0032695399     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01093.x     Document Type: Article

References (30)

1. 1 Watanabe T. HTLV-1-associated diseases. Int J Hematol 1997; 66:257-78.
2. 2 Vermont JC, Buisson G, Magdeleine J et al. T-lymphocyte alveolitis, tropic spastic paresis and Sjögren syndrome. Lancet 1988; i:177.
3. 3 Sugimoto M, Nakashima H, Watanabe S et al. T-lymphocyte alveolitis in HTLV-1-associated myelopathy. Lancet 1987; ii:1220.
4. 4 Couderc LI, Caubarrere I, Venet A et al. Bronchoalveolar lymphocytosis in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type-1 (HTLV-1): clinical, immunologic, and cytologic studies. Ann Intern Med 1988; 109:625-8.
5. 5 Maruyama M, Tihara J, Sakashita I et al. HTLV-1-associated bronchopneumopathy: a new clinical entity? Am Rev Respir Dis 1988; 137:46.
6. 6 Sugimoto M, Mita S, Tokunaga M et al. Pulmonary involvement in human T lymphotropic virus type-1 uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid. Eur Respir J 1993; 6:938-46.
7. 7 Sugimoto M, Nakashima H, Matsumoto M et al. Pulmonary involvement in patients with HTLV-1-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid. Am Rev Respir Dis 1989; 139:1329-35.
8. 8 Mukae H, Kohno S, Morikawa N et al. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-1 carriers. Microbiol Immunol 1994; 38:55-62.
9. 9 Noma T, Nakakubo H, Suguta M et al. Expression of different combinations of interleukins by human T cell leukemia cell lines that are clonally related. J Exp Med 1989; 169:1853-8.
10. 10 Tendler CL, Greenberg SJ, Burton JD et al. Cytokine induction in HTLV-1 associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 1991; 46:302-11.
11. 11 Baba M, Imai T, Yoshida T et al. Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type-1: rule of the viral transactivater Tax. Int J Cancer 1996; 66:124-9.
12. 12 Schall TJ, Jongstra J, Dyer BJ et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988; 141:1018-25.
13. 13 Zipfel PF, Balke J, Irving SG et al. Mitogcnic activation of human T cells induces two closely regulated genes which share structural similarities with a new family of secreted factors. J Immunol 1989; 142:1582-90.
14. 14 Harris ED Jr. Mechanisms of diseases: rheumatoid arthritis-pathophysiology and implications for therapy. N Engl J Med 1990; 322:1277-89.
15. 15 Moreland LW, Koopman WJ. Infection as a cause of arthritis. Curr Opin Rheumatol 1991; 3:639-49.
16. 16 Leung K, Nabel GJ. HTLV-1 transactivater induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature 1988; 333:776-8.
17. 17 Tendler CL, Greensberg SJ, Burton JD et al. Cytokine induction in HTLV-1 associated myelopathy and adult T cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 1991; 46:302-11.
18. 18 Umehara F, Izumo S, Nakagawa M et al. Immunocytochemical analysis of cellular infiltrate in the spinal cord lesions in HAM/TSP. J Neuropathol Exp Neurol 1993; 52:424-30.
19. 19 Higashiyama Y, Katamine S, Kohno S et al. Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals. Clin Exp Immunol 1994; 96:193-201.
20. 20 Miyagishi R, Kikuchi S, Fukazawa T et al. Macrophage inflammation protein-1α in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J Neuro Sci 1995; 129:223-7.
21. 21 Umehara F, Izumo S, Takeya M et al. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-1-associated myelopathy. Acta Neuropathl 1996; 91:343-50.
22. 22 Yoshimura T, Leonard EJ, Human monocyte chemoattractant protein-1. Cytokines 1992; 4:131-52.
23. 23 Koch AE, Kunkel SI, Harlow LA et al. Macrophage inflammatory protein-1α: a novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994; 93:921-8.
24. 24 Dennis M. Proinflammatory cytokines in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1995; 151:164-9.
25. 25 Conlon K, Lloid A, Chattopadhyay U et al. CD8+ and CD45RA -human peripheral blood lymphocytes are potent source of macrophage inflammatory protein 1α, interleukin-8, and RANTES. Eur J Immunol 1995; 25:751-6.
26. 26 Sugimoto M, Kitaichi M, Ikeda A et al. Chronic bronchioloalveolitis associated with human T-cell lymphotropic virus type 1 infection. Curr Opin Pul Med 1998; 4:98-102.
27. 27 Nakagawa M, Nakahara K, Maruyama Y et al. Therapeutic trials in 200 patients with HTLV-1 associated myelopathy/tropical spastic paraparesis. J Neurovirol 1996; 2:345-55.
28. 28 Oishi K, Sonoda F, Kobayashi S et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway disease. Infect Immun 1994; 62:4145-52.
29. 29 Khair OA, Devalia JL, Abdelaziz MM et al. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Euro Respir J 1995; 8:1451-7.
30. 30 Fujii T, Kadota J, Morikawa T et al. Inhibitory effect of erythromycin on interleukin 8 production by 1α, 25-dihydroxyvitamin D3-stimulated THP-1 cells. Antimicrob Agents Chemother 1996; 40:1548-51.